Spanish Industry invests in national economy
This article was originally published in Scrip
Over the next three years the Spanish pharmaceutical industry will invest €180 million in public research projects as part of its pledge to bolster the national economy, says Farmaindustria, Spain's pharmaceutical industry association.
You may also be interested in...
The R&D-based lobby group, Medicines Australia, has published a report calling for stakeholders across the Australian healthcare ecosystem to discuss how to “pragmatically address the evidence needs of the future.”
NICE will review new data in deciding whether to ok the use of Spinraza in non-ambulant SMA type III patients.
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.